A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer
Clinical trial NCT05658003 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05658003
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2024-12-02
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.